Overall rank by patents
#46,692
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 8 technology areas, active 2023–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C07C (ACYCLIC OR CARBOCYCLIC COMPOUNDS).
The verdict
Fermenta holds 5 US patents across 8 technology areas, rank #46,692 of 50,000 tracked assignees.
Fermenta Biotech Limited has been granted 5 US utility patents between 2023 and 2025, placing Fermenta Biotech Limited at rank #46,692 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.4 claims per patent with primary concentration in C07C (ACYCLIC OR CARBOCYCLIC COMPOUNDS). As a Foreign Corporation, Fermenta Biotech Limited is one of the more focused assignees in the PatentsView dataset. By volume, Fermenta sits between FCL Components Limited (5 patents, rank #46,688) and FIDA, Llc (5 patents, rank #46,696) - the closest US assignees by grant volume. The composite Innovation Score of 38.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2023 through 2025, with 5 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Fermenta Biotech Limited's 15.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 8 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Fermenta Biotech Limited against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
FCL Components Limited
5 patents
FD IP & LICENSING LLC
5 patents
FEMPRO CONSUMER PRODUCTS ULC
5 patents
FERDINAND-BRAUN-INSTITUT GGMBH, LEIBNIZ-INSTITUT FÜR HÖCHSTFREQUENZTECHNIK
5 patents
FETU LIMITED
5 patents
FFT Produktionssysteme GMBH & Co. KG
5 patents
FIBERON TECHNOLOGIES, INC.
5 patents
FIDA, LLC
5 patents
FERMENTA BIOTECH LIMITED
5 patents
What this shows Fermenta holds 5 patents at rank #46,692, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #46,692 in granted patent volume.
Other assignees with the most granted patents in Fermenta's primary technology class.
Fermenta's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
39 Top 40% higher than 60% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 2 | 40.0% |
| 2025 | 3 | 60.0% |
Top 8 of 8 technology areas
Overall rank by patents
#46,692
Across all tracked assignees
38.8 out of 100
How to use this portfolio
Fermenta's 5 grants land it in the top 40% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.